American Society for Clinical Pharmacology and Therapeutics Position Statement on Dietary Supplement Safety and Regulation
Pharmacogenetics and response to β-adrenergic receptor antagonists in heart failure
β-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure
Polymorphism screening in the cardiac K+ channel gene KCNA5
Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence
Influence of menstrual cycle on cytochrome P450 2A6 activity and cardiovascular effects of nicotine
Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability
Inhibition of human intestinal wall metabolism by macrolide antibiotics
Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure
BIBN4096BS antagonizes human α-calcitonin gene related peptide–induced headache and extracerebral artery dilatation
Peginterferon alfa-2a does not alter the pharmacokinetics of methadone in patients with chronic hepatitis C undergoing methadone maintenance therapy
Disposition of cisapride appears to be influenced by P-glycoprotein in the mouse
Modulation of celecoxib pharmacokinetics by food in pediatric patients
Limited association of the 2988G>A single nucleotide polymorphism with CYP2D6*41 in black subjects
Limited association of the 2988G>A single nucleotide polymorphism with CYP2D6*41 in black subjects
A MESSAGE FROM THE ASCPT MEMBERSHIP COMMITTEE CHAIRPERSON